601 results on '"Svenungsson E"'
Search Results
2. AB0998 PLASMA LEVELS OF GDF-15 ARE ASSOCIATED WITH ARTERIAL THROMBOSIS AND NEPHRITIS IN SYSTEMIC LUPUS ERYTHEMATOSUS
Catalog
Books, media, physical & digital resources
3. Sick leave and disability pension following delivery in women with systemic lupus erythematosus
4. Sick leave and disability pension following delivery in women with systemic lupus erythematosus
5. Regional European genetic ancestry predicts type I interferon level and risk of severe viral infection.
6. Genes identified in Asian SLE GWASs are also associated with SLE in Caucasian populations
7. Altered β2‐glycoprotein I expression on microparticles in the presence of antiphospholipid antibodies
8. POS0603 AUTOANTIBODIES AGAINST A SUBUNIT OF MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX I IN INCLUSION BODY MYOSITIS
9. AB0122 ANTI-HISTONE AND ANTI-NUCLEOSOME ANTIBODIES, RATHER THAN ANTI-DSDNA ANTIBODIES ARE ASSOCIATED WITH INTERFERON-INDUCED BIOMARKERS IN SUDANESE AND SWEDISH SLE PATIENTS
10. POS1410 PROTEOMIC ANALYSIS OF CUTANEOUS LUPUS ERYTHEMATOSUS AND DERMATOMYOSITIS DERMAL INFILTRATE REVEALS DIFFERENTIALLY EXPRESSED CANONICAL PATHWAYS
11. AB0540 COAGULATION AND HAEMOSTASIS PARAMETERS IN PREGNANT WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND HEALTHY CONTROLS WITH AND WITHOUT PREECLAMPSIA
12. POS1190-HPR WHY LUPUS? – PATIENTS’ THOUGHTS OF TRIGGERS OF SYSTEMIC LUPUS ERYTHEMATOSUS AND PERCEIVED HEALTH
13. POS1512 THROMBOCYTOPENIA AND IMPAIRED KIDNEY FUNCTION ARE MAJOR RISK FACTORS FOR RECURRENT THROMBOSIS IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME
14. AB0673 SERUM 25 (OH) VITAMIN D LEVELS AND BONE MINERAL DENSITY IN SYSTEMIC LUPUS ERYTHEMATOSUS
15. Pos0603 Autoantibodies against a Subunit of Mitochondrial Respiratory Chain Complex I in Inclusion Body Myositis
16. Prevention of cardiovascular disease in rheumatoid arthritis
17. PO.4.84 Infections in infants born to mothers with systemic lupus erythematosus and the role of preterm birth
18. PO.2.37 Risk factors for recurrent thrombosis and cause of death in patients with antiphospholipid syndrome; a Swedish cohort study
19. PO.1.20 Prognostic biomarkers of organ damage in patients with newly diagnosed SLE
20. S12.1 Il-16 – a urinary biomarker for proliferative lupus nephritis
21. PO.8.176 Inflammation in blood and placenta in SLE pregnancies
22. EULAR recommendations for womenʼs health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome
23. POS0747 ANTI-PHOSPHATIDYLSERINE/PROTHROMBIN ANTIBODIES AND VASCULAR EVENTS ASSOCIATE POSITIVELY WITH HLA-DRB1*13 AND NEGATIVELY WITH HLA-DRB1*03 IN SLE
24. AB0553 KIDNEY BIOPSY IN FIRST RENAL FLARE OF SLE – WHAT DOES IT TELL US?
25. POS1522-HPR COMPARISON OF EDUCATIONAL NEEDS AMONG PATIENTS WITH ANCA ASSOCIATED VASCULITIS AND SYSTEMIC LUPUS ERYTHEMATOSUS – A PILOT STUDY USING THE EDUCATIONAL NEEDS ASSESSMENT TOOL.
26. Long term outcome after a first myocardial infarction
27. Periodontitis and cardiovascular outcome – a prospective follow-up of the PAROKRANK cohort
28. Increased Serum Levels of the IL-33 Neutralizing sST2 in Limited Cutaneous Systemic Sclerosis
29. A5.8 The use of cardiovascular risk module within the swedish rheumatology quality registry (SRQ) helps in daily clinical praxis
30. EULAR RECOMMENDATION-BASED QUALITY INDICATORS (QIS) FOR SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): ELABORATION, FINAL SET, PERFORMANCE AND INITIAL VALIDATION
31. Quality indicators for systemic lupus erythematosus based on the 2019 EULAR recommendations: Development and initial validation in a cohort of 220 patients
32. Global epidemiology of systemic lupus erythematosus.
33. Publisher Correction: Global epidemiology of systemic lupus erythematosus (Nature Reviews Rheumatology, (2021), 17, 9, (515-532), 10.1038/s41584-021-00668-1).
34. Periodontitis and cardiovascular outcome - a prospective follow-up of the PAROKRANK cohort
35. Long term outcome after a first myocardial infarction
36. POS0184 URINE-GALECTINE 3 BINDING PROTEIN (U-GAL3BP) IS A SENSITIVE MARKER OF KIDNEY INFLAMMATION AND RESPONSE TO TREATMENT IN LUPUS
37. POS0779 MYOCARDIAL INFARCTIONS, SUBTYPES, LOCATIONS AND CORONARY ATHEROSCLEROSIS IN SLE - A COMPARATIVE STUDY WITH MATCHED CONTROLS
38. AB0318 RISK FOR CONCOMITANT AUTOIMMUNITY IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME; A SWEDISH COHORT STUDY
39. POS0764 EULAR RECOMMENDATION-BASED QUALITY INDICATORS (QIS) FOR SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): ELABORATION, FINAL SET, PERFORMANCE AND INITIAL VALIDATION
40. POS0009 THE RELATIONSHIP BETWEEN DIFFERENT IGG AND IGA ANTI-MODIFIED PROTEIN AUTOANTIBODIES IN RHEUMATOID ARTHRITIS
41. POS1425 ANTIBODIES TO PORPHYROMONAS GINGIVALIS ASSOCIATE WITH THE PRESENCE OF RHEUMATOID ARTHRITIS-RELATED AUTOANTIBODIES IN PATIENTS WITH PERIODONTITIS
42. No evidence of association between genetic variants of the PDCD1 ligands and SLE
43. Elevated IgA antiphospholipid antibodies in healthy pregnant women in Sudan but not Sweden, without corresponding increase in IgA anti-β2 glycoprotein I domain 1 antibodies
44. The R620W C/T polymorphism of the gene PTPN22 is associated with SLE independently of the association of PDCD1
45. Increased levels of thrombin activatable fibrinolysis inhibitor - TAFI in patients with the antiphospholipid syndrome: PA 1.18–3
46. Contribution of IKBKE and IFIH1 gene variants to SLE susceptibility
47. Association analysis with microsatellite and SNP markers does not support the involvement of BCL-2 in systemic lupus erythematosus in Mexican and Swedish patients and their families
48. Poster session: Aortic stenosis
49. Neurological side-effects of TNF-α blocking agents. A report of 39 cases: SC118
50. Anti-factor H autoantibodies in systemic lupus erythematosus: P187
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.